MedTrace Logo

Effect of Lactium on Sleep Disorders in Healthy Volunteers With Persistent Subclinical Insomnia

NCT06378034 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2024-04-22

No results posted yet for this study

Summary

The main objective will be to assess the effect of Lactium® on sleep efficiency in volunteers presented with persistent subclinical insomnia.

Conditions

  • Sleep Disorder

Interventions

DIETARY_SUPPLEMENT

Lactium

300 mg per day, taken 30 min to 60 min before bedtime

DIETARY_SUPPLEMENT

Placebo

300 mg per day, taken 30 min to 60 min before bedtime

Sponsors & Collaborators

  • Ingredia S.A.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-06-10
Primary Completion
2024-07-15
Completion
2026-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06378034 on ClinicalTrials.gov